Health Care & Life Sciences » Biotechnology | Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
82,361.10
115,204.10
167,045.10
277,554.70
364,931.20
485,079.60
Depreciation, Depletion & Amortization
19,190.20
27,719.40
33,162.60
49,803.20
53,260.90
66,543.90
Other Funds
2,000.00
-
490,711.00
349.00
14,637.90
29,291
Funds from Operations
101,562.30
145,622.40
176,573.30
328,388.90
405,279.80
578,949.40
Changes in Working Capital
12,455.70
23,731.80
31,195.50
129,632.80
427,861.10
543,336.10
Net Operating Cash Flow
89,106.50
121,890.60
145,377.80
198,756.10
22,581.30
35,613.20
Capital Expenditures
32,896.90
47,892.40
159,373.70
300,085.30
232,384.50
Sale of Fixed Assets & Businesses
33.10
423.70
416.30
88.50
960.10
Purchase/Sale of Investments
45,944.50
98,500.30
99,991.10
100,712.00
17,201.80
Net Investing Cash Flow
178,214.40
134,469.00
283,726.10
399,198.70
369,893.10
Cash Dividends Paid - Total
37,900.00
37,900.00
45,480.00
53,477.00
26,738.50
Issuance/Reduction of Debt, Net
-
-
45,145.00
23,000.00
505,000.00
Net Financing Cash Flow
35,900.00
37,900.00
490,376.00
76,826.00
463,623.60
Net Change in Cash
125,007.90
50,478.40
352,027.70
277,268.60
71,149.20
Free Cash Flow
56,209.60
73,998.20
13,995.90
101,329.10
254,965.80
Deferred Taxes & Investment Tax Credit
18.80
3,440.00
516.20
509.60
10,791.20
1,965.10
Net Assets from Acquisitions
72,906.10
-
24,777.60
-
155,670.50
Other Sources
-
26,500.00
-
1,510.00
-
Other Uses
26,500.00
15,000.00
-
-
-

About Jiangxi Boya Bio-Pharmaceutical Co.

View Profile
Address
333 Huiquan Road
Fuzhou Jiangxi 344000
China
Employees -
Website http://www.china-boya.com
Updated 07/08/2019
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.